The medical community utilizes Imatinib Tablets IP 400 mg as a treatment option for targeted cancer therapy. The drug disrupts particular proteins which lead to uncontrolled cell growth. Imatinib Tablets IP 400 mg enable patients to achieve longer treatment periods while delaying disease progression. https://quickbloging.com/how-imatinib-tablets-ip-400-mg-help-manage-chronic-myeloid-leukemia/